Literature DB >> 34082257

Playing hide and seek: Tumor cells in control of MHC class I antigen presentation.

M L M Jongsma1, J Neefjes1, R M Spaapen2.   

Abstract

MHC class I (MHC-I) molecules present a blueprint of the intracellular proteome to T cells allowing them to control infection or malignant transformation. As a response, pathogens and tumor cells often downmodulate MHC-I mediated antigen presentation to escape from immune surveillance. Although the fundamental rules of antigen presentation are known in detail, the players in this system are not saturated and new modules of regulation have recently been uncovered. Here, we update the understanding of antigen presentation by MHC-I molecules and how this can be exploited by tumors to prevent exposure of the intracellular proteome. This knowledge can provide new ways to improve immune responses against tumors and pathogens.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antigen presentation; Antigen processing; Cancer; HLA; Immune escape; MHC class I

Year:  2021        PMID: 34082257     DOI: 10.1016/j.molimm.2021.05.009

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter "Tissue-Specific" Region.

Authors:  Cesidio Giuliani; Sara Verrocchio; Fabio Verginelli; Ines Bucci; Antonino Grassadonia; Giorgio Napolitano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-06       Impact factor: 5.555

2.  Prognostic Risk Signature and Comprehensive Analyses of Endoplasmic Reticulum Stress-Related Genes in Lung Adenocarcinoma.

Authors:  CaiZhen Yang; YuHui Wei; WenTao Li; JinMei Wei; GuoXing Chen; MingPeng Xu; GuangNan Liu
Journal:  J Immunol Res       Date:  2022-05-04       Impact factor: 4.818

3.  Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma.

Authors:  Jing Yu; Xi Wu; Jinen Song; Yujie Zhao; Huifang Li; Min Luo; Xiaowei Liu
Journal:  Front Pharmacol       Date:  2022-08-26       Impact factor: 5.988

4.  Identification of glycogene signature as a tool to predict the clinical outcome and immunotherapy response in breast cancer.

Authors:  Shuai Lin; Zengqi Tan; Hanxiao Cui; Qilong Ma; Xuyan Zhao; Jianhua Wu; Luyao Dai; Huafeng Kang; Feng Guan; Zhijun Dai
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.